Ubenimex, also known more commonly as bestatin, is a competitive, reversible protease inhibitor. It is an inhibitor of arginyl aminopeptidase, leukotriene A₄ hydrolase, alanyl aminopeptidase, leucyl/cystinyl aminopeptidase, and membrane dipeptidase. Chemically, it is a small peptide-like amino acid derivative that mimics the N-terminal residues of natural substrates and binds the catalytic pocket of zinc-dependent aminopeptidases, blocking substrate hydrolysis without covalent modification of the enzyme. In research and development it is used as a biochemical tool to probe aminopeptidase function, to modulate peptide processing in immune and inflammatory pathways, and in preclinical models to study roles in tumor biology and leukotriene metabolism. The material is supplied as a white to off-white crystalline powder, soluble in water and polar aprotic solvents such as DMSO, stable under refrigerated storage, and typically characterized by HPLC for assay and related substances, by Karl Fischer titration for moisture, and by ICP-MS or colorimetric methods for residual metals.
Parent: Ubenimex
Parent: Ubenimex
Parent: Ubenimex
Parent: Ubenimex
Parent: Ubenimex
Typical specification limits for Ubenimex active pharmaceutical ingredient include assay by HPLC 98.0 to 102.0 percent on a dry basis, individual related substances not greater than 0.5 percent each by area percent, total impurities not greater than 1.0 percent by area percent, unspecified impurities not greater than 0.1 percent, residual solvents controlled per ICH Q3C with common solvents such as methanol limited to 3000 parts per million and ethanol to 5000 parts per million when used, water content by Karl Fischer not greater than 1.5 percent, and heavy metals not greater than 10 parts per million. Identification is performed by retention time matching and MS confirmation, and degradation studies under forced conditions define known degradants that are then included in the related-compounds profile for routine release testing.
Ubenimex is used primarily as a biochemical inhibitor of aminopeptidases to study peptide metabolism, immune modulation, and inflammatory mediator pathways in vitro and in vivo; it has also been investigated clinically as an adjuvant agent in oncology and immunotherapy settings and is applied in translational research to interrogate the effects of aminopeptidase inhibition on cell signaling and leukotriene pathways.
